108 related articles for article (PubMed ID: 1504417)
21. Effect of anti-PcrV antibody in a murine chronic airway Pseudomonas aeruginosa infection model.
Imamura Y; Yanagihara K; Fukuda Y; Kaneko Y; Seki M; Izumikawa K; Miyazaki Y; Hirakata Y; Sawa T; Wiener-Kronish JP; Kohno S
Eur Respir J; 2007 May; 29(5):965-8. PubMed ID: 17301098
[TBL] [Abstract][Full Text] [Related]
22. Immunoglobulin A antibodies against Pseudomonas aeruginosa in the tear fluid of contact lens wearers.
Cheng KH; Spanjaard L; Rutten H; Dankert J; Polak BC; Kijlstra A
Invest Ophthalmol Vis Sci; 1996 Sep; 37(10):2081-8. PubMed ID: 8814147
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of the adherence of Pseudomonas aeruginosa to epithelial cells by IgG subclass antibodies.
Morrin M; Reen DJ
J Med Microbiol; 1993 Dec; 39(6):459-66. PubMed ID: 8246266
[TBL] [Abstract][Full Text] [Related]
24. IgG subclass antibodies to Pseudomonas aeruginosa in sera from patients with chronic Ps. aeruginosa infection investigated by ELISA.
Pressler T; Pedersen SS; Espersen F; Høiby N; Koch C
Clin Exp Immunol; 1990 Sep; 81(3):428-34. PubMed ID: 2118845
[TBL] [Abstract][Full Text] [Related]
25. Mucosal immunity to Pseudomonas aeruginosa alginate in cystic fibrosis.
Pedersen SS; Møller H; Espersen F; Sørensen CH; Jensen T; Høiby N
APMIS; 1992 Apr; 100(4):326-34. PubMed ID: 1581041
[TBL] [Abstract][Full Text] [Related]
26. [Comparison of immunological aspects in diffuse panbronchiolitis and cystic bronchiectasis].
Sato A
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Mar; 28(3):404-9. PubMed ID: 2214379
[TBL] [Abstract][Full Text] [Related]
27. Pseudomonas-infected cystic fibrosis patient sputum inhibits the bactericidal activity of normal human serum.
Schiller NL; Millard RL
Pediatr Res; 1983 Sep; 17(9):747-52. PubMed ID: 6413945
[TBL] [Abstract][Full Text] [Related]
28. Serum IgA antibodies against Pseudomonas aeruginosa in cystic fibrosis.
Brett MM; Ghoneim AT; Littlewood JM
Arch Dis Child; 1990 Mar; 65(3):259-63. PubMed ID: 2110441
[TBL] [Abstract][Full Text] [Related]
29. Role of chronic Pseudomonas aeruginosa infection in the development of bronchiectasis.
Nagaki M; Shimura S; Tanno Y; Ishibashi T; Sasaki H; Takishima T
Chest; 1992 Nov; 102(5):1464-9. PubMed ID: 1424868
[TBL] [Abstract][Full Text] [Related]
30. Serum IgG and sputum IgA antibody to core lipopolysaccharide antigen from Pseudomonas cepacia in patients with cystic fibrosis.
Nelson JW; Butler SL; Brown PH; Greening AP; Govan JR
J Med Microbiol; 1993 Jul; 39(1):39-47. PubMed ID: 7686977
[TBL] [Abstract][Full Text] [Related]
31. Haemophilus influenzae infections in patients with chronic obstructive pulmonary disease despite specific antibodies in serum and sputum.
Groeneveld K; Eijk PP; van Alphen L; Jansen HM; Zanen HC
Am Rev Respir Dis; 1990 May; 141(5 Pt 1):1316-21. PubMed ID: 2339850
[TBL] [Abstract][Full Text] [Related]
32. IgG, IgA, and IgM antibodies to mite in sera and sputa from asthmatic patients.
Kitani S; Ito K; Miyamoto T
Ann Allergy; 1985 Oct; 55(4):612-20. PubMed ID: 3876792
[TBL] [Abstract][Full Text] [Related]
33. Anti-Pseudomonas aeruginosa antibody detection in patients with bronchiectasis without cystic fibrosis.
Caballero E; Drobnic ME; Pérez MT; Manresa JM; Ferrer A; Orriols R
Thorax; 2001 Sep; 56(9):669-74. PubMed ID: 11514685
[TBL] [Abstract][Full Text] [Related]
34. A study of bronchus-associated lymphoid tissue in a rat model of chronic pulmonary infection with Pseudomonas aeruginosa.
Kitazawa H; Sato A; Iwata M
Kansenshogaku Zasshi; 1997 Mar; 71(3):214-21. PubMed ID: 9128005
[TBL] [Abstract][Full Text] [Related]
35. Intrapulmonary concentrations of inflammatory cytokines in a mouse model of chronic respiratory infection caused by Pseudomonas aeruginosa.
Yanagihara K; Tomono K; Kuroki M; Kaneko Y; Sawai T; Ohno H; Miyazaki Y; Higashiyama Y; Maesaki S; Kadota J; Kohno S
Clin Exp Immunol; 2000 Oct; 122(1):67-71. PubMed ID: 11012620
[TBL] [Abstract][Full Text] [Related]
36. Pseudomonas aeruginosa antibodies in human plasma.
Doi T; Yoshioka M; Nakajima T
Jpn J Exp Med; 1976 Jun; 46(3):149-54. PubMed ID: 60502
[TBL] [Abstract][Full Text] [Related]
37. Variable antibiotic susceptibility in populations of Pseudomonas aeruginosa infecting patients with bronchiectasis.
Gillham MI; Sundaram S; Laughton CR; Haworth CS; Bilton D; Foweraker JE
J Antimicrob Chemother; 2009 Apr; 63(4):728-32. PubMed ID: 19193658
[TBL] [Abstract][Full Text] [Related]
38. The prophylactic effects of human IgG derived from sera containing high anti-PcrV titers against pneumonia-causing Pseudomonas aeruginosa.
Kinoshita M; Kato H; Yasumoto H; Shimizu M; Hamaoka S; Naito Y; Akiyama K; Moriyama K; Sawa T
Hum Vaccin Immunother; 2016 Nov; 12(11):2833-2846. PubMed ID: 27454613
[TBL] [Abstract][Full Text] [Related]
39. Antibody to multiple mucoid strains of Pseudomonas aeruginosa in patients with cystic fibrosis, measured by an enzyme-linked immunosorbent assay.
Baltimore RS; Fick RB; Fino L
Pediatr Res; 1986 Nov; 20(11):1085-90. PubMed ID: 3099248
[TBL] [Abstract][Full Text] [Related]
40. [Susceptibility of bacteria isolated from the patients with lower respiratory tract infections to antibiotics (1985)].
Ikemoto H; Watanabe K; Kosakai N; Hayashi Y; Oguri T; Saito A; Shinohara M; Matsumiya H; Ueda K; Terai T
Jpn J Antibiot; 1987 Sep; 40(9):1669-97. PubMed ID: 3121887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
